25
Participants
Start Date
June 30, 2022
Primary Completion Date
August 31, 2025
Study Completion Date
June 30, 2027
HSCT Arm group
"Conditioning regimen Stem cell source Only Bone Marrow With a minimal target dose of 4x108 nucleated cells/kg recipient ideal body weight. If the graft is less rich than the minimum target dose, it can be administered at the discretion to the physician.~GVHD Prophylaxis Prevention of EBV reactivation : Rituximab 150mg/m2 IV at Day+5 post HSCT."
Assistance Publique - Hôpitaux de Paris
OTHER